American Association of Endocrine Surgeons| Volume 128, ISSUE 6, P1013-1021, December 2000

Download started.


Randomized trial of parathyroidectomy in mild asymptomatic primary hyperparathyroidism: Patient description and effects on the SF-36 health survey


      Background. The treatment of patients with asymptomatic primary hyperparathyroidism remains controversial despite a National Institutes of Health consensus statement. This statement also recommended a randomized clinical trial because none exists to address this issue. Methods. Informed consent was obtained from 53 asymptomatic patients with confirmed asymptomatic primary hyperparathyroidism who participated in this randomized trial of parathyroidectomy versus observation. Patients completed the SF-36 Health Survey, an instrument that measures wellness, every 6 months for 2 years. Average annual changes were compared. Results. Fifty-three patients (42 female, 11 male) with asymptomatic, mild (serum calcium level, 10.1-11.5 mg/dL) asymptomatic primary hyperparathyroidism who agreed to participate were randomized into either a surgical group or an observation group. The mean calcium level was 10.31 mg/dL. The only demographic difference between groups was age, with the operative group being older (66.7 vs 62.6 years; P <.03). The scores on 2 of the 9 domains of the SF-36 were significantly different (P <.007 and <.012, respectively); both favored the operative group. Conclusions. Improved function is seen after parathyroidectomy when compared with patients who did not undergo operation. This study supports surgical management of mild primary hyperparathyroidism at the time of diagnosis because many patients have reversible nonclassic symptoms of the disease. (Surgery 2000;128:1013-21.)
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


      1. J Bone Miner Res. 1991; 6: 9-13
        • Scholz DA
        • Purnell DC
        Asymptomatic primary hyperparathyroidism: 10-year prospective study.
        Mayo Clin Proc. 1981; 56: 473-478
        • Ljunghall S
        • Jakobsson S
        • Joborn C
        • Palmer M
        • Rastad J
        • Akerstrom G
        Longitudinal studies of mild primary hyperparathyroidism.
        J Bone Miner Res. 1991; 6: S111-S116
        • Hedback G
        • Oden A
        • Tisell LE
        The influence of surgery on the risk of death in patients with primary hyperparathyroidism.
        World J Surg. 1991; 15: 399-407
        • Silverberg SJ
        • Shane E
        • Jacobs TP
        • Siris E
        • Bilezikian JP
        A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery.
        N Engl J Med. 1999; 341: 1249-1255
        • Smit PC
        • van Dalen A
        • van Vroonhoven TJ
        Strategy in asymptomatic and mildly symptomatic primary hyperparathyroidism, new arguments for the surgical option. Netherlands.
        J Med. 1998; 52: 95-99
        • Silverberg S
        • Bilezikian JP
        • Bone HG
        • Talpos GB
        • Horwitz MJ
        • Stewart AF
        Therapeutic controversies in primary hyperparathyroidism.
        J Clin Endocrinol Metab. 1999; 84: 2275-2285
        • Ware JE
        • Sherbourne CD
        The MOS 36-item short-form health survey (SF-36): I, conceptual framework and item selection.
        Med Care. 1992; 30: 473-483
      2. How to score the SF-36 health survey. : Medical Outcomes Trust, Boston1994
        • SAS Institute Inc
        SAS/STAT software: changes and enhancements for release 6.12.
        : SAS Institute, Cary (NC)1996
        • Boonstra CE
        • Jackson CE
        Serum calcium survey for hyperparathyroidism results in 50,000 clinic patients.
        Am J Clin Pathol. 1971; 55: 523-526
        • Chan AK
        • Duh QY
        • Katz MH
        • Siperstein AE
        • Clark OH
        Clinical manifestations of primary hyperparathyroidism before and after parathyroidectomy: a case-control study.
        Ann Surg. 1995; 222: 402-414
        • Burney RE
        • Jones KR
        • Coon JW
        • Blewitt DK
        • Herm AM
        Assessment of patient outcomes after operation for primary hyperparathyroidism.
        Surgery. 1996; 120: 1013-1019
        • Burney RE
        • Jones KR
        • Peterson M
        • Christy B
        • Thompson NW
        Surgical correction of primary hyperparathyroidism improves quality of life.
        Surgery. 1998; 124: 987-992
        • Burney RE
        • Jones KR
        • Christy B
        • Thompson N
        Health status improvement after surgical correction of primary hyperparathyroidism in patients with high and low preoperative calcium levels.
        Surgery. 1999; 15: 608
        • Ware JE
        SF-36 health survey: manual and interpretation guide.
        : Health Institute, New England Medical Center, Boston1993